Big movers on D-Street: What should investors do with Aurobindo Pharma, Tanla Platforms and IDBI Bank?

Sensex and Nifty hit record highs, driven by PSU banks and foreign inflows. Aurobindo Pharma rose 20%, with an overbought RSI, trading 9.5% above the mean. Tanla Platforms nears its 50-week average, trading sideways. IDBI Bank shows strong demand at 76, with the highest quarterly trading volume, and momentum approaching breakout.

Benchmark Sensex and Nifty closed at new record high levels on Monday following buying in PSU bank shares and fresh foreign fund inflows.

Stocks that were in focus include names like , which soared 3.67%, , which gained 5.69%, and , whose shares Jumped 6.79% on Monday.

Here's what Kushal Gandhi, Technical Analyst at StoxBox, recommends investors should do with these stocks when the market resumes trading today.

Aurobindo Pharma

The recent price action of Auro Pharma indicates strong leadership within its sector. The stock has reached all-time highs and experienced a substantial increase of nearly 20% over the last 12 trading sessions.

However, the daily RSI has entered the overbought zone, and the price is trading 9.5% above the mean, suggesting a potential for profit booking. As a result, we advise against purchasing Auro Pharma at its current high market price.

Tanla Platforms

After rising more than 5,500%, the stock price of Tanla Platforms experienced some profit-taking and dropped by over 70%. Recently, the price has stabilized after the correction and is trading sideways, potentially showing bullish strength.

Although the relative strength has underperformed, the stock has been seeing improvements in its EPS strength and attracting buyers.

The price is currently close to its 50-week moving average, presenting a low-risk and potentially high-reward opportunity for a new long entry with a target price of 1245 and a stop loss at 918.

IDBI Bank

The analysis of the daily price movement of IDBI reveals that it is currently trading within a descending triangle pattern. The area around the 76 levels acts as a strong demand zone and has seen significant technical rebounds from that level.

On Monday, the price sharply rose with a substantial increase in trading volume, the highest recorded in the quarter, and an upsurge in momentum approaching the breakout point. Both the daily and higher timeframe Relative Strength Index (RSI) are well above their midpoints and do not indicate any divergence from the price, suggesting strong momentum in the price trend. We recommend buying IDBI with a target price of 104 and a stop loss of 86.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source: Stocks-Markets-Economic Times